Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The ev company has 4 times that in contracts! Imo that'll be announced in the filings. Good times ahead indeed
I'll be back after the fins are released. To laugh at all these jokers.
Price will be well over .20 by then imo
Can people not read the stickies? Lol
ITS ALL THERE.
lol I'm very long. Shit I'd wait a few years to watch this go up. Good thing the FDA will be giving us some news soon.
Offshore shorting?! Lmao now I've heard it all
These financials are gonna be fun to look at. I guess the sellers here can't read? The DD has already been done haha all you have to do is literally read
To all the DD masters here: thank you
Glad I stumbled upon this a couple weeks ago.
Easily
Just wait til people read some of the DD on all of this lol she's gonna move FAST
Couldn't type fast enough to get my order for more in jeezus!
So what does the number 6 mean? Lol
This will be most read board over the weekend I think
Is this where I write BOOM?
Initially got in at 014 haha enjoying these opps to average down. Nobody can find a hole in the DD here! Got all the time in the world
60 days had a lil pause for additional information requests, which as per my FDA link last weekend is VERY common for any FDA approval process
Treatment of degenerative disks
https://www.ncbi.nlm.nih.gov/m/pubmed/28086781/
With RMAT it'll be WHEN buyout
Imo
So, to answer the original question.
YES the FDA will give RMAT designation to a company with only 20 patients in a clinical trial. The precedent has been set.
Hippo did all the work here:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129883281
Gotta dig through it all, but it's there. Us stem cell has plenty of data in the archives, imo
Yes, phase 3 is in the works. But they COMPLETED phase 2 of 20 patients.
Humacyte is currently undertaking a Phase III clinical trial of HUMACYL compared to an expanded polytetrafluoroethylene (ePTFE) graft in 350 patients with kidney failure who are not candidates for fistula placement. The trial involves approximately 35 sites in the U.S., Europe and Israel. The Phase III study’s primary objective is to compare the durable use (secondary patency) of the HAV with that of the ePTFE graft during its use as a conduit for hemodialysis. The company published Phase II results in May 2016, showing HUMACYL may have the potential for long-term use and safety in patients suffering from ESRD who require renal replacement therapy and are not candidates for fistula.
After RMAT they won't be worrying about money haha neither will I. 10 new clinics, now that's a lot of future clinical data
Umm humacyte. 20 patients. RMAT designation.
See the thing is us stem cell got creative in accumulating their data. Lot more than the 20 patients of data out there. Mexico. Europe. Asia.
Spot on analysis!
Maybe to be announced in conjunction with RMAT news
FDA RMAT designation. Understand it's significance. Read nomodo's sticky! Commercialization won't be far off
Hmm embryonic stem cells from baby fetuses or adipose stem cells from fat? Which will trumps FDA prefer.. hmmmm? No wonder why Mr. Harvard is so bitter lol
I stopped reading at "desperate to save her sight" lol cool. The dinosaur was ALREADY going blind.
I have never said that. Wrong poster dude
Smart man
Traders dream here. Jeezus. FDA news will be fun for us longs
Imo bidding war has already begun. Behind the scenes.
Someone's been accumulating. That we know
There will be no massive sell off after RMAT designation
I suggest reading nomodo's sticky
And then hippos tam model
Then bust out the calculator
Definitely been ihub money keepin this green 11/13 HAHA
Someone wants to take over
Been holding this and forgetting about it. Have a feeling I'll check back in a couple days and I'll be very happy
I expect whichever group or institution that's accumulating this stock to continue to do so all week. No doubt that some entity is loading this baby. I have my theories on that. Probably will continue to churn or move slightly up here until news this week or next. That's when the fun will start
The thing about charts... they aren't factoring in imminent FDA news. Could be tomorrow. Could be next Friday. BUT ITS COMING:)
Pretty funny haha but he's been charting for 10 years so I guess it's going down haha
Charts don't work when outside pharma money is pouring in son